These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 18566180)
1. Biochemical and hematologic alterations following percutaneous cryoablation of liver tumors: experience in 48 procedures. Nair RT; Silverman SG; Tuncali K; Obuchowski NA; vanSonnenberg E; Shankar S Radiology; 2008 Jul; 248(1):303-11. PubMed ID: 18566180 [TBL] [Abstract][Full Text] [Related]
2. Percutaneous imaging-guided cryoablation of liver tumors: predicting local progression on 24-hour MRI. Shyn PB; Mauri G; Alencar RO; Tatli S; Shah SH; Morrison PR; Catalano PJ; Silverman SG AJR Am J Roentgenol; 2014 Aug; 203(2):W181-91. PubMed ID: 24555531 [TBL] [Abstract][Full Text] [Related]
3. Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: a comparison of the safety of cryoablation and radiofrequency ablation. Dunne RM; Shyn PB; Sung JC; Tatli S; Morrison PR; Catalano PJ; Silverman SG Eur J Radiol; 2014 Apr; 83(4):632-8. PubMed ID: 24529593 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of coagulopathy following percutaneous cryoablation of liver tumors: experience in 372 patients. Shi J; Niu L; Huang Z; Mu F; Chen J; Li J; Xu K Cryobiology; 2013 Oct; 67(2):146-50. PubMed ID: 23830952 [TBL] [Abstract][Full Text] [Related]
6. Cryoprotective therapy for huge hepatocellular carcinoma: a study of 14 patients with a single lesion. Alnaggar M; Niu L; Li J; Yao F; Wang Y; Zeng J; Ye J; Chen J; Mu F; Xu K Cryobiology; 2014 Dec; 69(3):457-61. PubMed ID: 25445461 [TBL] [Abstract][Full Text] [Related]
7. Cryoprotective therapy for hepatocellular carcinoma: study of 51 patients with a single lesion. Ali AM; Lizhi N; Jialiang L; Fei Y; Yuan W; Jianying Z; Jin Y; Jibing C; Feng M; Kecheng X Cryobiology; 2014 Aug; 69(1):61-7. PubMed ID: 24859156 [TBL] [Abstract][Full Text] [Related]
8. Liver Function Tests Following Irreversible Electroporation of Liver Tumors: Experience in 174 Procedures. Froud T; Venkat SR; Barbery KJ; Gunjan A; Narayanan G Tech Vasc Interv Radiol; 2015 Sep; 18(3):140-6. PubMed ID: 26365543 [TBL] [Abstract][Full Text] [Related]
9. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation--initial observations. Allaf ME; Varkarakis IM; Bhayani SB; Inagaki T; Kavoussi LR; Solomon SB Radiology; 2005 Oct; 237(1):366-70. PubMed ID: 16126920 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma and liver cirrhosis: assessment of the liver function after Yttrium-90 radioembolization with resin microspheres or after CT-guided high-dose-rate brachytherapy. Rühl R; Seidensticker M; Peters N; Mohnike K; Bornschein J; Schütte K; Amthauer H; Malfertheiner P; Pech M; Ricke J Dig Dis; 2009; 27(2):189-99. PubMed ID: 19546558 [TBL] [Abstract][Full Text] [Related]
12. Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. series. Littrup PJ; Aoun HD; Adam B; Krycia M; Prus M; Shields A Abdom Radiol (NY); 2016 Apr; 41(4):767-80. PubMed ID: 26960728 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous renal cryoablation: local control at mean 26 months of followup. Atwell TD; Callstrom MR; Farrell MA; Schmit GD; Woodrum DA; Leibovich BC; Chow GK; Patterson DE; Blute ML; Charboneau JW J Urol; 2010 Oct; 184(4):1291-5. PubMed ID: 20719341 [TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Lu DS; Yu NC; Raman SS; Limanond P; Lassman C; Murray K; Tong MJ; Amado RG; Busuttil RW Radiology; 2005 Mar; 234(3):954-60. PubMed ID: 15681691 [TBL] [Abstract][Full Text] [Related]